期刊
JOURNAL OF CLINICAL IMMUNOLOGY
卷 42, 期 4, 页码 837-850出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-022-01218-4
关键词
Primary immunodeficiency; activated phosphoinositide 3-kinase delta syndrome; tuberculosis; rapamycin; glucocorticoid; HSCT
类别
资金
- Natural Science Foundation of China [81974255, 81620108014]
This study reviewed the clinical features, immunological characteristics, treatment, and prognosis of Chinese pediatric patients with APDS. The study found that sinopulmonary infections and lymphoproliferation were the most common complications in this cohort, while autoimmunity was also frequently observed.
Purpose Activated phosphoinositide 3-kinase delta syndrome (APDS) is a primary immunodeficiency first described in 2013, which is caused by gain-of-function mutations in PIK3CD or PIK3R1, and characterized by recurrent respiratory tract infections, lymphoproliferation, herpesvirus infection, autoimmunity, and enteropathy. We sought to review the clinical phenotypes, immunological characteristics, treatment, and prognosis of APDS in a large genetically defined Chinese pediatric cohort. Methods Clinical records, radiology examinations, and laboratory investigations of 40 APDS patients were reviewed. Patients were contacted via phone call to follow up their current situation. Results Sinopulmonary infections and lymphoproliferation were the most common complications in this cohort. Three (10.3%) and five (12.5%) patients suffered localized BCG-induced granulomatous inflammation and tuberculosis infection, respectively. Twenty-seven patients (67.5%) were affected by autoimmunity, while malignancy (7.5%) was relatively rare to be seen. Most patients in our cohort took a combined treatment of anti-infection prophylaxis, immunoglobulin replacement, and immunosuppressive therapy such as glucocorticoid or rapamycin administration. Twelve patients underwent hematopoietic stem cell transplantation (HSCT) and had a satisfying prognosis. Conclusion Clinical spectrum of APDS is heterogeneous. This cohort's high incidence of localized BCG-induced granulomatous inflammation and tuberculosis indicates Mycobacterial susceptibility in APDS patients. Rapamycin is effective in improving lymphoproliferation and cytopenia. HSCT is an option for those who have severe complications and poor response to other treatments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据